GSK
892 hedge funds and large institutions have $13.5B invested in GSK in 2019 Q4 according to their latest regulatory filings, with 143 funds opening new positions, 295 increasing their positions, 287 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
892
Holders Change
+88
Holders Change %
+10.95%
% of All Funds
17.61%
Holding in Top 10
16
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+14.29%
% of All Funds
0.32%
New
143
Increased
295
Reduced
287
Closed
45
Calls
$163M
Puts
$128M
Net Calls
+$35.3M
Net Calls Change
+$3.43M
Top Buyers
Top Sellers
| 1 |
Dodge & Cox
San Francisco,
California
|
$2.18B |
| 2 |
Two Sigma Investments
New York
|
$31.8M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
$200M |
| 4 |
Jane Street
New York
|
$83.7M |
| 5 |
BHC
Bowen Hanes & Co
Ponte Vedra Beach,
Florida
|
$5.91M |